Elaine Castellanos is CAO & VP at REATA PHARMACEUTICALS INC (RETA). They have made 17 open-market trades across 1 company since 2018, most recently 2021-06-09.
CIK 0001662520
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RETA | 15,182 | $2.6M |
Shares reported on the most recent Form 4, priced at the 2021-06-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RETA | SELL | 2021-06-07 | 2021-06-09 | $143.20 | $1.7M | -2.3% | +0.5% | -20.3% |
| RETA | SELL | 2021-05-26 | 2021-05-27 | $124.55 | $1.2M | +2.7% | +9.9% | -21.7% |
| RETA | SELL | 2020-11-12 | 2020-11-13 | $176.02 | $616K | -13.2% | -32.5% | -29.8% |
| RETA | SELL | 2020-06-01 | 2020-06-01 | $143.97 | $288K | +19.3% | +9.5% | -25.3% |
| RETA | SELL | 2020-03-02 | 2020-03-02 | $194.32 | $389K | -29.2% | -36.2% | -32.7% |
| RETA | SELL | 2019-12-02 | 2019-12-03 | $194.24 | $388K | +2.1% | +2.3% | +2.7% |
| RETA | SELL | 2019-10-28 | 2019-10-30 | $200.00 | $800K | +4.9% | -4.2% | -4.6% |
| RETA | SELL | 2019-10-25 | 2019-10-28 | $190.00 | $380K | +2.5% | -3.6% | -3.3% |
| RETA | SELL | 2019-10-18 | 2019-10-21 | $170.00 | $340K | +14.3% | +18.1% | +18.1% |
| RETA | SELL | 2019-10-15 | 2019-10-17 | $145.52 | $1.7M | +18.1% | +21.5% | +23.8% |
| RETA | SELL | 2019-10-15 | 2019-10-17 | $147.59 | $2.1M | +18.1% | +21.5% | +23.8% |
| RETA | SELL | 2019-10-14 | 2019-10-15 | $105.00 | $315K | +23.6% | +28.2% | +27.3% |
| RETA | SELL | 2019-09-06 | 2019-09-10 | $85.00 | $170K | +6.2% | -3.2% | +128.3% |
| RETA | SELL | 2019-06-03 | 2019-06-05 | $85.20 | $170K | -3.7% | +2.0% | -14.9% |
| RETA | SELL | 2019-04-08 | 2019-04-09 | $90.17 | $180K | -10.3% | +0.8% | +1.8% |
| RETA | SELL | 2019-03-05 | 2019-03-07 | $102.00 | $366K | +3.3% | -2.0% | -2.3% |
| RETA | SELL | 2018-07-23 | 2018-07-25 | $50.81 | $738K | -6.9% | -1.8% | -24.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.